A multicenter, open label study to evaluate the efficacy and safety of tigecycline to treat complicated intra-abdominal infections (cIAI) in hospitalized patients
Phase of Trial: Phase IV
Latest Information Update: 05 Dec 2007
At a glance
- Drugs Tigecycline (Primary)
- Indications Bacterial infections; Intra-abdominal infections
- Focus Therapeutic Use
- Sponsors Wyeth
- 05 Dec 2007 Status changed from recruiting to completed according to ClinicalTrials.gov.
- 16 Jul 2007 New trial record.